{
  "ptid_time": "067_S_0076_2007-03-12",
  "img_path": "/data/qiuhui/data/adni/images/067_S_0076/2007-03-12/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 33,589 mm³, 12.8% below the reference mean. With a Z-score of -0.31 (38.0th percentile), this represents normal volume ; hippocampal volume measures 4,436 mm³, 41.3% below the reference mean. With a Z-score of -4.03 (0.0th percentile), this represents profound atrophy; whole brain volume measures 915,267 mm³, 15.2% below the reference mean. With a Z-score of -1.97 (2.4th percentile), this represents moderate atrophy; entorhinal cortex volume measures 1,843 mm³, 55.1% below the reference mean. With a Z-score of -3.73 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 14,296 mm³, 24.1% below the reference mean. With a Z-score of -2.05 (2.0th percentile), this represents significant atrophy; middle temporal gyrus volume measures 15,628 mm³, 26.8% below the reference mean. With a Z-score of -2.41 (0.8th percentile), this represents significant atrophy. ",
  "text_data": "Age is 79.3 years. Gender is Male. Education: 12 years. MMSE: 26.0. Logical Memory: 1.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 552.10 pg/mL (mild reduced); Total tau: 478.80 pg/mL (profound elevated); Phosphorylated tau: 50.21 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows profound atrophy in the hippocampus and entorhinal cortex, which are key regions affected in Alzheimer's disease (AD), along with significant atrophy in the fusiform gyrus and middle temporal gyrus. The CSF biomarkers (Aβ mildly reduced, T-tau and P-tau profoundly elevated) strongly support AD pathology. The MMSE score of 26 is borderline but aligns with early dementia given the structural and biomarker evidence.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**",
  "timestamp": "2025-07-26T08:24:49.416804"
}